Qualitative findings highlight gaps in patient education, access to evidence-based interventions, and understanding of the experiences of people with multiple sclerosis and bladder and bowel dysfunction across cultures and health care systems.
The private and taboo nature associated with bowel dysfunction restricts people from talking openly with their health care team.
More data are needed to ascertain the actual risks and benefits of DMT use, discontinuation, and de-escalation in older people with MS.
IJMSC Author Spotlight shines a light on the people behind the research.
Although psychological therapies demonstrate benefits in people with multiple sclerosis across several domains, this study identifies potential mechanisms of action and characteristics of those likely to benefit.